Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy

被引：2

作者：

Butz, T. ^{[1
,2
]}

Horstkotte, D. ^{[2
]}

Koerfer, J. ^{[3
]}

Langer, C. ^{[2
]}

Seggewiss, H. ^{[4
]}

Faber, L. ^{[2
]}

机构：

[1] Ruhr Univ Bochum, Dept Cardiol & Angiol, Marienhosp, D-44627 Herne, Germany

[2] Ruhr Univ Bochum, Dept Cardiol, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany

[3] Ruhr Univ Bochum, Inst Radiol Nucl Med & Mol Imaging, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany

[4] Leopoldina Hosp Schweinfurt, Schweinfurt, Germany

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2010年 / 145卷 / 01期

关键词：

Hypertrophic obstructive cardiomyopathy; Septal ablation; PTSMA; Magnetic resonance imaging; MRI; Myocardial scar; VENTRICULAR OUTFLOW TRACT;

D O I：

10.1016/j.ijcard.2008.12.096

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report on a 60 year-old male who was one of the first patients who underwent percutaneous transluminal septal myocardial ablation (PTSMA) in our institution in 1996. Contrast enhanced cardiac magnetic resonance imaging (MRI) 11 years after the PTSMA demonstrated extensive scarring, in septal and inferior segments of the left ventricle, and an excellent functional result. It has been previously demonstrated that contrast-enhanced MRI allows detailed evaluation of size and location of septal myocardial infarction induced by PTSMA, and that infarction size detected by MRI correlates well with clinical indexes of infarct size. Our case report underlines the importance of ongoing specialized care and reassessment of patients after PTSMA including continuous clinical risk assessment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：E3 / E5

页数：3

共 9 条

[1] Ethical authorship and publishing [J].

Coats, Andrew J. S. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) :149-150

[2] Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy - Results with respect to intraprocedural myocardial contrast echocardiography [J].

Faber, L ;

Seggewiss, H ;

Gleichmann, U .

CIRCULATION, 1998, 98 (22) :2415-2421

[3] Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy [J].

Maron, Barry J. ;

Spirito, Paolo ;

Shen, Win-Kuang ;

Haas, Tammy S. ;

Formisano, Francesco ;

Link, Mark S. ;

Epstein, Andrew E. ;

Almquist, Adrian K. ;

Daubert, James P. ;

Lawrenz, Thorsten ;

Boriani, Giuseppe ;

Estes, N. A. Mark, III ;

Favale, Stefano ;

Piccininno, Marco ;

Winters, Stephen L. ;

Santini, Massimo ;

Betocchi, Sandro ;

Arribas, Fernando ;

Sherrid, Mark V. ;

Buja, Gianfranco ;

Semsarian, Christopher ;

Bruzzi, Paolo .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (04) :405-412

[4] Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance [J].

Moon, JCC ;

McKenna, WJ ;

McCrohon, JA ;

Elliott, PM ;

Smith, GC ;

Pennell, DJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) :1561-1567

[5] The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization [J].

Schulz-Menger, J ;

Strohm, O ;

Waigand, J ;

Uhlich, F ;

Dietz, R ;

Friedrich, MG .

CIRCULATION, 2000, 101 (15) :1764-1766

[6] Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy [J].

Schulz-Menger, Jeanette ;

Abdel-Aty, Hassan ;

Busjahn, Andreas ;

Wassmuth, Ralf ;

Pilz, Bernhard ;

Dietz, Rainer ;

Friedrich, Matthias G. .

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2006, 8 (05) :741-746

[7] Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy [J].

Seggewiss, H. ;

Rigopoulos, A. ;

Welge, D. ;

Ziemssen, P. ;

Faber, L. .

CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (12) :856-863

[8] NONSURGICAL MYOCARDIAL REDUCTION FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [J].

SIGWART, U .

LANCET, 1995, 346 (8969) :211-214

[9] Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy [J].

Valeti, Uma S. ;

Nishimura, Rick A. ;

Holmes, David R. ;

Araoz, Philip A. ;

Glockner, James F. ;

Breen, Jerome F. ;

Ommen, Steve R. ;

Gersh, Bernard J. ;

Tajik, A. Jamil ;

Rihal, Charanjit S. ;

Schaff, Hartzell V. ;

Maron, Barry J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (03) :350-357

← 1 →